← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Nortis, Inc.
Bothell, WA
$10,987,968
Total funding
11
Grants
Funding over time
peak $3M · FY2010–23$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$10,987,968 · 11
By mechanism
R44$7,967,612 · 5
N44$1,988,728 · 1
R43$366,642 · 3
R41$365,000 · 1
N43$299,986 · 1
Investigators at Nortis, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
IGF::OT::IGF SBIR PHASE II TOPIC 314, TITLE: A VASCULARIZED TUMOR-MICROENVIRONMENT ASSAY FOR THE SCREENING OF ANTI-CANCER DRUGS$1,988,728
N44 · FY2015 · CA
Development of pharmacokinetic assays utilizing an organ-on-chip model of the human kidney proximal tubule$1,024,842
R44 · FY2020 · TR
Development of pharmacokinetic assays utilizing an organ-on-chip model of the human kidney proximal tubule$1,024,820
R44 · FY2021 · TR
Rat and Canine Microphysiological Systems of the Kidney Proximal Tubule for Chemical Toxicity Screening$876,058
R44 · FY2021 · ES
Rat and Canine Microphysiological Systems of the Kidney Proximal Tubule for Chemical Toxicity Screening$803,596
R44 · FY2022 · ES
Development of an Advanced In-Vitro Model for Angiogenesis Research and Drug Test$770,090
R44 · FY2014 · HL
Development of an Advanced In-Vitro Model for Angiogenesis Research and Drug Test$739,884
R44 · FY2015 · HL
A microfluidic platform for modeling drug transport and cell trafficking across the blood-brain barrier$700,895
R44 · FY2016 · NS
A microfluidic platform for modeling drug transport and cell trafficking across the blood-brain barrier$687,731
R44 · FY2017 · NS
Development of pharmacokinetic assays utilizing an organ-on-chip model of the human kidney proximal tubule$331,413
R44 · FY2019 · TR
A microfluidic quality-control assay for stem-cell derived therapies$325,000
R41 · FY2016 · TR
Organ-on-chip based assays for personalized assessment of renal resilience in aging patients$300,000
R43 · FY2019 · AG
IGF::OT::IGF SUPPORT- ADMINISTRATIVE: OTHER$299,986
N43 · FY2013 · CA
A liver-on-chip platform to evaluate panels of clinically relevant gene variants for screening of xenobiotic compounds$275,453
R44 · FY2023 · ES
Organ-on-Chip Approach for Assessing Tissue-specific SARS-CoV-2 Infection and Response to Antiviral Therapy$255,716
R44 · FY2020 · TR
Rat and Canine Microphysiological Systems of the Kidney Proximal Tubule for Chemical Toxicity Screening$252,114
R44 · FY2020 · ES
A microfluidic platform for modeling drug transport and cell trafficking across the blood-brain barrier$225,000
R44 · FY2015 · NS
Development of an Advanced In-Vitro Model for Angiogenesis Research and Drug Test$42,507
R43 · FY2011 · HL
Microfluidic Platform for Stem Cell Applications$40,000
R41 · FY2016 · TR
Development of a Vascularized In-Vitro Model of the Tumor Microenvironment$24,135
R43 · FY2010 · CA